Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents
about
Antibiotic treatment of animals infected with Borrelia burgdorferiComparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migransFormation and cultivation of Borrelia burgdorferi spheroplast-L-form variantsUltrastructure of Borrelia burgdorferi after exposure to benzylpenicillinIneffectiveness of tigecycline against persistent Borrelia burgdorferiEffectiveness of antimicrobial treatment against Borrelia burgdorferi infection in mice.Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.Review of treatment options for lyme borreliosis.Culture of the entire mouse to determine whether cultivable Borrelia burgdorferi persists in infected mice treated with a five-day course of Ceftriaxone.Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatmentSustained-release formulation of doxycycline hyclate for prophylaxis of tick bite infection in a murine model of Lyme borreliosisIn vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone.Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents.Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.Erythromycin resistance in Borrelia burgdorferi.Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis.Efficacy of clarithromycin for treatment of experimental Lyme disease in vivo.In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.In vitro susceptibility of Borrelia burgdorferi isolates to three antibiotics commonly used for treating equine Lyme disease.In vitro antibiotic susceptibilities of Borrelia isolates from erythema migrans lesion of Lyme disease patients in Japan.In vitro and in vivo evaluation of cephalosporins for the treatment of Lyme disease
P2860
Q24650857-5D6F5415-244C-4A33-A530-03176F5B38D9Q24678610-37FCB26B-7A6F-45EE-A19A-DDFC820A21ACQ28290164-CAE1B625-E5AD-4C3F-8AAE-4E90DE9F4167Q28298953-9E5282AB-5DC4-47FD-8CBE-FB1E545DBF40Q33613691-15E26DEA-A95F-4926-A650-821259E0D035Q33754842-A1007B40-6917-4A06-8BE6-C297B9A6F2DAQ34336214-55ACC7E6-D68D-42FD-9479-5029277C20E7Q34471224-59158D02-40A1-4815-983C-7ECC6C43D673Q34596959-EA99E89B-4EB9-430C-AED7-325D528124C1Q34736995-D8822AC8-215C-4F2F-B310-6840B0DB3FDDQ35125790-63E922BE-52E1-4AE0-8F26-6DB06D7104B1Q35129412-2CE93342-1894-45E4-9E64-78248EFC1B2CQ35815090-0DD9639B-17AE-44CE-8652-95D94802A32EQ35894499-E7AC55F8-EA2E-452C-85D4-EBA9BF04C91EQ36679488-56408A6E-D0AF-4D15-98F9-36BC05B459ECQ38695328-5429D9AD-F57D-41BF-8CF5-D38087B43FB0Q39472473-509D7C6C-BFFA-4A16-836A-21AA7A436F9AQ39657790-A4B2D85D-519B-4CC8-95A6-2D9485D7F495Q39781985-8FCD9645-CA9F-463A-B1F1-D96ABB28F94FQ39866191-ABEBE352-4E3B-4BB3-9321-10A6E752AA7DQ39866294-C9DF6CF6-6B3D-4BF1-B7C3-161265AA0EDAQ42183764-5A96C16E-1EA7-49AD-9329-CEF83AD0085CQ43538629-B0BF31C5-9F6B-4452-A69A-3E4B9189AF6EQ57952389-D73CDF4F-8998-49FA-AB39-B933F327A851
P2860
Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Comparative in vitro and in vi ...... and other antimicrobial agents
@ast
Comparative in vitro and in vi ...... and other antimicrobial agents
@en
type
label
Comparative in vitro and in vi ...... and other antimicrobial agents
@ast
Comparative in vitro and in vi ...... and other antimicrobial agents
@en
prefLabel
Comparative in vitro and in vi ...... and other antimicrobial agents
@ast
Comparative in vitro and in vi ...... and other antimicrobial agents
@en
P2093
P2860
P356
P1476
Comparative in vitro and in vi ...... and other antimicrobial agents
@en
P2093
C B Kodner
J J Collins
P J Jurkovich
R C Johnson
P2860
P304
P356
10.1128/AAC.34.11.2133
P407
P577
1990-11-01T00:00:00Z